SEC Form 3 · accession 0001144204-17-061997
Ensysce Biosciences, Inc. · ENSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Rittvo
Director
Period of report
Dec 1, 2017
Accepted (ET)
Dec 1, 2017 · 6:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001716947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.